Suppr超能文献

影响血浆衍生微粒体组织因子活性测量的分析前和分析变量。

Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity.

机构信息

Division of Hematology/Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

出版信息

Thromb Res. 2012 Jan;129(1):80-5. doi: 10.1016/j.thromres.2011.06.004. Epub 2011 Jul 6.

Abstract

INTRODUCTION

Elevated levels of tissue factor positive (TF(+)) microparticles (MPs) are observed in plasma from a variety of patients with an increased risk of thrombosis. We and others have described the measurement of TF activity in MPs isolated from plasma. The aim of this study was to investigate the effects of pre-analytical and analytical variables on TF activity of MPs isolated from blood of healthy volunteers either untreated or treated ex vivo with bacterial lipopolysaccharide.

MATERIALS AND METHODS

We evaluated the following parameters: use of different centrifugation speeds to isolate the MPs; comparison of TF activity of MPs isolated from platelet poor plasma versus platelet free plasma; effect of freeze/thaw on MP TF activity; and comparison of the MP TF activity assay with the measurement of TF protein by ELISA or flow cytometry.

RESULTS

MPs prepared from platelet poor plasma by centrifugation at 20,000×g or 100,000×g for 15 minutes had similar levels of TF activity. However, significantly less TF activity was found in MPs isolated from platelet free plasma compared with platelet poor plasma. Interestingly, freeze/thawing of the plasma showed donor to donor variation in MP TF activity, with a moderate increase in some individuals.

CONCLUSION

TF(+) MPs can be quantitatively isolated from platelet poor or platelet free plasma by centrifugation at 20,000×g for 15 minutes. Measurement of MP TF activity in plasma may be used to detect a prothrombotic state in patients with various diseases.

摘要

简介

在具有较高血栓形成风险的各种患者的血浆中观察到组织因子阳性(TF(+))微粒(MPs)水平升高。我们和其他人已经描述了从血浆中分离的 MPs 中 TF 活性的测量。本研究的目的是研究分析前和分析变量对来自健康志愿者血液的 MPs 中 TF 活性的影响,这些 MPs 未经处理或离体用细菌脂多糖处理。

材料和方法

我们评估了以下参数:使用不同的离心速度来分离 MPs;比较从血小板贫乏血浆与无血小板血浆中分离的 MPs 的 TF 活性;冻融对 MPs TF 活性的影响;以及 MPs TF 活性测定与 ELISA 或流式细胞术测量 TF 蛋白的比较。

结果

用 20,000×g 或 100,000×g 离心 15 分钟从血小板贫乏血浆中制备的 MPs 具有相似水平的 TF 活性。然而,与血小板贫乏血浆相比,从无血小板血浆中分离的 MPs 中发现的 TF 活性明显较少。有趣的是,血浆的冻融显示出供体间 MPs TF 活性的差异,在一些个体中中等增加。

结论

TF(+) MPs 可以通过在 20,000×g 下离心 15 分钟从血小板贫乏或无血小板血浆中定量分离。血浆中 MPs TF 活性的测量可用于检测各种疾病患者的血栓形成前状态。

相似文献

1
Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity.
Thromb Res. 2012 Jan;129(1):80-5. doi: 10.1016/j.thromres.2011.06.004. Epub 2011 Jul 6.
4
Evaluation of microparticles in whole blood by multicolour flow cytometry assay.
Scand J Clin Lab Invest. 2013 Apr;73(3):229-39. doi: 10.3109/00365513.2013.769278. Epub 2013 Mar 1.
6
Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism.
Thromb Res. 2010 Jun;125(6):511-2. doi: 10.1016/j.thromres.2009.09.019. Epub 2009 Oct 24.
9
High concentration of the plasma microparticles for venous thromboembolism associated with lung cancer.
Clin Respir J. 2020 May;14(5):481-487. doi: 10.1111/crj.13158. Epub 2020 Feb 19.
10
Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay.
Thromb Res. 2011 Apr;127(4):370-7. doi: 10.1016/j.thromres.2010.12.014. Epub 2011 Jan 22.

引用本文的文献

1
The pathogenesis of cancer-associated thrombosis.
Int J Hematol. 2024 May;119(5):495-504. doi: 10.1007/s12185-024-03735-x. Epub 2024 Feb 29.
2
Evaluation of the ability of commercial enzyme-linked immunosorbent assays to measure mouse tissue factor.
Res Pract Thromb Haemost. 2024 Jan 26;8(1):102325. doi: 10.1016/j.rpth.2024.102325. eCollection 2024 Jan.
3
Cancer-Associated Thrombosis: Epidemiology, Pathophysiological Mechanisms, Treatment, and Risk Assessment.
Clin Med Insights Oncol. 2023 Dec 26;17:11795549231220297. doi: 10.1177/11795549231220297. eCollection 2023.
5
Plasma Clot Properties in Patients with Pancreatic Cancer.
Cancers (Basel). 2023 Aug 9;15(16):4030. doi: 10.3390/cancers15164030.
6
Characterization of extracellular vesicles in COVID-19 infection during pregnancy.
Front Cell Dev Biol. 2023 Jul 25;11:1135821. doi: 10.3389/fcell.2023.1135821. eCollection 2023.
7
Detection of tissue factor-positive extracellular vesicles using the ExoView R100 system.
Res Pract Thromb Haemost. 2023 May 16;7(4):100177. doi: 10.1016/j.rpth.2023.100177. eCollection 2023 May.
8
Evaluation of four commercial ELISAs to measure tissue factor in human plasma.
Res Pract Thromb Haemost. 2023 Mar 28;7(3):100133. doi: 10.1016/j.rpth.2023.100133. eCollection 2023 Mar.
9
Monocyte Tissue Factor Expression: Lipopolysaccharide Induction and Roles in Pathological Activation of Coagulation.
Thromb Haemost. 2023 Nov;123(11):1017-1033. doi: 10.1055/a-2091-7006. Epub 2023 May 11.
10
Mechanisms of cancer-associated thrombosis.
Res Pract Thromb Haemost. 2023 Mar 15;7(3):100123. doi: 10.1016/j.rpth.2023.100123. eCollection 2023 Mar.

本文引用的文献

1
Pre-analytical and analytical issues in the analysis of blood microparticles.
Thromb Haemost. 2011 Mar;105(3):396-408. doi: 10.1160/TH10-09-0595. Epub 2010 Dec 21.
2
Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma.
Thromb Haemost. 2011 Jan;105(1):14-20. doi: 10.1160/TH10-03-0187. Epub 2010 Nov 5.
3
Tissue factor and its measurement in whole blood, plasma, and microparticles.
Semin Thromb Hemost. 2010 Nov;36(8):865-75. doi: 10.1055/s-0030-1267040. Epub 2010 Nov 3.
4
Overcoming limitations of microparticle measurement by flow cytometry.
Semin Thromb Hemost. 2010 Nov;36(8):807-18. doi: 10.1055/s-0030-1267034. Epub 2010 Nov 3.
5
A multicolor flow cytometric assay for measurement of platelet-derived microparticles.
Thromb Res. 2010 Mar;125(3):e110-6. doi: 10.1016/j.thromres.2009.10.006. Epub 2009 Nov 24.
6
Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism.
Thromb Res. 2010 Jun;125(6):511-2. doi: 10.1016/j.thromres.2009.09.019. Epub 2009 Oct 24.
7
Microparticle-associated tissue factor activity in cancer patients with and without thrombosis.
J Thromb Haemost. 2009 Aug;7(8):1421-3. doi: 10.1111/j.1538-7836.2009.03504.x. Epub 2009 Jun 3.
8
Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer.
J Thromb Haemost. 2008 Nov;6(11):1983-5. doi: 10.1111/j.1538-7836.2008.03156.x. Epub 2008 Sep 15.
9
Flow cytometric measurement of microparticles: pitfalls and protocol modifications.
Platelets. 2008 Aug;19(5):365-72. doi: 10.1080/09537100802054107.
10
Circulating tissue factor-exposing microparticles.
Thromb Res. 2008;122 Suppl 1:S47-54. doi: 10.1016/S0049-3848(08)70019-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验